scispace - formally typeset
E

Elizabeth Ercolano

Researcher at Yale University

Publications -  52
Citations -  1826

Elizabeth Ercolano is an academic researcher from Yale University. The author has contributed to research in topics: Cancer & Distress. The author has an hindex of 16, co-authored 46 publications receiving 1443 citations. Previous affiliations of Elizabeth Ercolano include Yale Cancer Center.

Papers
More filters
Journal ArticleDOI

Self-management: Enabling and empowering patients living with cancer as a chronic illness†‡

TL;DR: The Chronic Care Model is presented as a model of care that oncology practices can use to enable and empower patients and families to engage in self‐management in order to build strong relationships with their patients and formulate mutually agreed upon care plans.
Journal ArticleDOI

Effects of a nursing intervention on quality of life outcomes in post-surgical women with gynecological cancers

TL;DR: Women with gynecological cancers have reported poor health‐related quality of life (QOL), with complex physical and psychological needs post‐surgery and during chemotherapy treatment, and there are no studies reporting interventions addressing these needs post-hospital discharge.
Journal ArticleDOI

Self-management for adult patients with cancer: an integrative review.

TL;DR: Current interventions that direct patients in self-care management of symptoms and associated challenges with cancer/survivorship are helpful, but incomplete.
Journal ArticleDOI

A chronic care ostomy self-management program for cancer survivors

TL;DR: Individuals with ostomies experience extensive changes in health‐related quality of life (HRQOL) and daily routine and patients and families are typically forced to use trial and error to improve self‐management.
Journal ArticleDOI

An Advanced Practice Nurse Coordinated Multidisciplinary Intervention for Patients with Late-Stage Cancer: A Cluster Randomized Trial.

TL;DR: It is demonstrated that if patients newly diagnosed with late-stage cancer were managed by disease-specific multidisciplinary teams who palliated their symptoms, providing whole-patient care, patient outcomes remained stable or improved.